We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
AUM
$129M
AUM Growth
+$12.5M
Cap. Flow
+$1.51M
Cap. Flow %
1.17%
Top 10 Hldgs %
35.17%
Holding
250
New
36
Increased
56
Reduced
56
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 23.54%
2 Technology 15.89%
3 Financials 10.33%
4 Consumer Discretionary 9.2%
5 Communication Services 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
126
Lowe's Companies
LOW
$122B
$196K 0.15%
+1,182
New +$182K
PSX icon
127
Phillips 66
PSX
$82.5B
$196K 0.15%
3,800
-1,600
-30% -$97.6K
DHR icon
128
Danaher
DHR
$140B
$193K 0.15%
1,015
-113
-10% -$20.1K
CL icon
129
Colgate-Palmolive
CL
$74.2B
$192K 0.15%
2,500
OKTA icon
130
Okta
OKTA
$23.7B
$191K 0.15%
892
+90
+11% +$18.8K
DLTR icon
131
Dollar Tree
DLTR
$24.4B
$183K 0.14%
1,900
CMCSA icon
132
Comcast
CMCSA
$85.8B
$182K 0.14%
3,935
+880
+29% +$38.3K
BKLN icon
133
Invesco Senior Loan ETF
BKLN
$6.97B
$181K 0.14%
8,359
+3,769
+82% +$81.9K
DVY icon
134
iShares Select Dividend ETF
DVY
$24.1B
$180K 0.14%
2,211
-6,662
-75% -$556K
PEP icon
135
PepsiCo
PEP
$195B
$179K 0.14%
1,294
+644
+99% +$87.6K
INDA icon
136
iShares MSCI India ETF
INDA
$6.84B
$169K 0.13%
5,000
NSC icon
137
Norfolk Southern
NSC
$76.1B
$167K 0.13%
784
+284
+57% +$57K
HSY icon
138
Hershey
HSY
$37.2B
$164K 0.13%
1,150
+150
+15% +$21.3K
FDIS icon
139
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.64B
$162K 0.13%
2,626
PLRX icon
140
Pliant Therapeutics
PLRX
$66.3M
$160K 0.12%
7,100
+1,100
+18% +$27.5K
VDC icon
141
Vanguard Consumer Staples ETF
VDC
$8.14B
$160K 0.12%
981
+15
+2% +$2.42K
FHLC icon
142
Fidelity MSCI Health Care Index ETF
FHLC
$3.37B
$142K 0.11%
2,700
LHX icon
143
L3Harris
LHX
$56.9B
$141K 0.11%
830
+25
+3% +$4.38K
DOC icon
144
Healthpeak Properties
DOC
$15.7B
$140K 0.11%
5,176
SNX icon
145
TD Synnex
SNX
$19.8B
$140K 0.11%
2,000
-15,600
-89% -$981K
XBI icon
146
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$140K 0.11%
1,258
-5
-0.4% -$561
WDAY icon
147
Workday
WDAY
$39.4B
$139K 0.11%
+650
New +$129K
ZTS icon
148
Zoetis
ZTS
$32.5B
$137K 0.11%
+835
New +$128K
CCXI
149
DELISTED
ChemoCentryx, Inc.
CCXI
$137K 0.11%
2,500
WAT icon
150
Waters Corp
WAT
$37.7B
$136K 0.11%
700

Similar funds

Grace Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Grace Capital held 250 positions worth $129M, up 11% from $116M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Grace Capital's Q3 2020 filing shows 36 new, 56 increased, 56 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 164,389 shares worth $7M. The largest sale was Portola Pharmaceuticals, Inc., an estimated $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Grace Capital's largest Q3 2020 buy was Relay Therapeutics: 164,389 shares worth $7M.
  • Grace Capital added most to Apple in Q3 2020, an estimated $3.49M increase.
  • Grace Capital's biggest Q3 2020 reduction was Vanguard Mega Cap Growth ETF, cutting an estimated $1.55M.
  • Grace Capital fully exited Portola Pharmaceuticals, Inc. in Q3 2020, selling an estimated $2.3M.
  • Grace Capital's ten largest holdings make up 35% of its $129M portfolio in Q3 2020.
  • Grace Capital opened 36 new positions and closed 11 in Q3 2020.
  • Grace Capital's portfolio value rose 11% quarter-over-quarter to $129M.

Based on Grace Capital's 13F filing for Q3 2020, filed 12 Nov 2020.